279 related articles for article (PubMed ID: 18326020)
21. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.
Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H
Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895
[TBL] [Abstract][Full Text] [Related]
22. Cyclin D1 expression does not effect cell proliferation in adenoid cystic carcinoma of the salivary gland.
Yasumatsu R; Kuratomi Y; Nakashima T; Masuda M; Yamamoto T
Eur Arch Otorhinolaryngol; 2004 Nov; 261(10):526-30. PubMed ID: 14714130
[TBL] [Abstract][Full Text] [Related]
23. Prognostic implications of NUMB immunoreactivity in salivary gland carcinomas.
Maiorano E; Favia G; Pece S; Resta L; Maisonneuve P; Di Fiore PP; Capodiferro S; Urbani U; Viale G
Int J Immunopathol Pharmacol; 2007; 20(4):779-89. PubMed ID: 18179751
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of apoptosis and apoptosis-associated proteins in salivary gland adenoid cystic carcinoma.
Jia L; Esguerra RL; Tang X; Yin H; Sakamoto K; Okada N; Takagi M
Pathol Int; 2004 Apr; 54(4):217-23. PubMed ID: 15028021
[TBL] [Abstract][Full Text] [Related]
25. The role of p53 mutation and protein expression in primary and recurrent adenoid cystic carcinoma.
Papadaki H; Finkelstein SD; Kounelis S; Bakker A; Swalsky PA; Kapadia SB
Hum Pathol; 1996 Jun; 27(6):567-72. PubMed ID: 8666366
[TBL] [Abstract][Full Text] [Related]
26. Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands.
Kiyoshima T; Shima K; Kobayashi I; Matsuo K; Okamura K; Komatsu S; Rasul AM; Sakai H
Oral Oncol; 2001 Apr; 37(3):315-22. PubMed ID: 11287288
[TBL] [Abstract][Full Text] [Related]
27. Detection of MYB Alterations and Other Immunohistochemical Markers in Primary Cutaneous Adenoid Cystic Carcinoma.
North JP; McCalmont TH; Fehr A; van Zante A; Stenman G; LeBoit PE
Am J Surg Pathol; 2015 Oct; 39(10):1347-56. PubMed ID: 26076064
[TBL] [Abstract][Full Text] [Related]
28. Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12.
Guan H; Tan J; Zhang F; Gao L; Bai L; Qi D; Dong H; Zhu L; Li X; Liu T
Histopathology; 2015 May; 66(6):781-90. PubMed ID: 25098606
[TBL] [Abstract][Full Text] [Related]
29. Over-expression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis.
Sasaki M; Yamaguchi J; Itatsu K; Ikeda H; Nakanuma Y
J Pathol; 2008 Jun; 215(2):175-83. PubMed ID: 18393368
[TBL] [Abstract][Full Text] [Related]
30. Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance.
Sun J; Luo Y; Tian Z; Gu L; Xia SC; Yu Y
BMC Cancer; 2012 Oct; 12():499. PubMed ID: 23110497
[TBL] [Abstract][Full Text] [Related]
31. Expression of Submaxillary Gland Androgen-regulated Protein 3A (SMR3A) in Adenoid Cystic Carcinoma of the Head and Neck.
Thierauf J; Veit JA; Grünow J; Döscher J; Weißinger S; Whiteside T; Beutner D; Quaas A; Plinkert P; Hoffmann TK; Hess J
Anticancer Res; 2016 Feb; 36(2):611-5. PubMed ID: 26851015
[TBL] [Abstract][Full Text] [Related]
32. Early stage minor salivary gland adenoid cystic carcinoma has favourable prognosis.
Hämetoja H; Hirvonen K; Hagström J; Leivo I; Saarilahti K; Apajalahti S; Haglund C; Mäkitie A; Bäck L
Virchows Arch; 2017 Dec; 471(6):785-792. PubMed ID: 28600602
[TBL] [Abstract][Full Text] [Related]
33. Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma.
Beltran D; Faquin WC; Gallagher G; August M
J Oral Maxillofac Surg; 2006 Mar; 64(3):415-23. PubMed ID: 16487803
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct.
Sasaki M; Matsubara T; Yoneda N; Nomoto K; Tsuneyama K; Sato Y; Nakanuma Y
Histopathology; 2013 Feb; 62(3):446-57. PubMed ID: 23163606
[TBL] [Abstract][Full Text] [Related]
35. Salivary gland tumors: immunohistochemical study of EGF, EGFR, ErbB-2, FAS and Ki-67.
Ito FA; Ito K; Coletta RD; Graner E; de Almeida OP; Lopes MA
Anal Quant Cytol Histol; 2009 Oct; 31(5):280-7. PubMed ID: 20701095
[TBL] [Abstract][Full Text] [Related]
36. EZH2 is a sensitive marker of malignancy in salivary gland tumors.
Hajósi-Kalcakosz S; Vincze E; Dezső K; Paku S; Rókusz A; Sápi Z; Tóth E; Nagy P
Diagn Pathol; 2015 Sep; 10():163. PubMed ID: 26377323
[TBL] [Abstract][Full Text] [Related]
37. Concomitant expression of ezrin and HER2 predicts distant metastasis and poor prognosis of patients with salivary gland carcinomas.
Hashimoto K; Hayashi R; Mukaigawa T; Yamazaki M; Fujii S
Hum Pathol; 2017 May; 63():110-119. PubMed ID: 28300573
[TBL] [Abstract][Full Text] [Related]
38. High podoplanin and low E-cadherin levels correlate with better prognosis in adenoid cystic carcinoma.
van der Wal JE; Sgaramella N; Norberg Spaak L; Zborayova K; Nylander K
Clin Exp Dent Res; 2019 Aug; 5(4):350-355. PubMed ID: 31452946
[TBL] [Abstract][Full Text] [Related]
39. Glycoconjugate expression in adenoid cystic carcinoma of the salivary glands: up-regulation of L1 predicts fatal prognosis.
Dahl A; Teegen J; Altevogt P; Löning T; Schumacher U
Histopathology; 2011 Aug; 59(2):299-307. PubMed ID: 21884209
[TBL] [Abstract][Full Text] [Related]
40. Predictors of Outcome in Adenoid Cystic Carcinoma of Salivary Glands: A Clinicopathologic Study With Correlation Between MYB Fusion and Protein Expression.
Xu B; Drill E; Ho A; Ho A; Dunn L; Prieto-Granada CN; Chan T; Ganly I; Ghossein R; Katabi N
Am J Surg Pathol; 2017 Oct; 41(10):1422-1432. PubMed ID: 28719465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]